Actualizado 21/11/2008 15:31
- Comunicado -

CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients (y 2)

    
    References
    1. Enbrel EMEA SPC.
       http://www.emea.europa.eu/humandocs/PDFs/EPAR/Enbrel/H-262-P...
    2. Christophers E. Psoriasis - Epidemiology and Clinical Spectrum. Clin
       Exp Dermatol 2001;26:314-320
    3. National Psoriasis Fund. Plaque Psoriasis.
       http://www.psoriasis.org/about/psoriasis... . Accessed October
       2008
    4. Mrowietz, U et al. The importance of disease associations and
       concomitant therapy for the long-term management of Psoriasis patients
       Arch Dermatol Res (2006)
    5. Paller, AS et al. Etanercept treatment for children and adolescents
       with plaque psoriasis. N Engl J Med 2008;358:241-51

For further information, please contact: Wyeth: Gill Markham, Communications - Europe, Middle East and Africa, Direct Tel: +44-1628-692536, Email: markhagl@wyeth.com ; Danielle Halstrom, Communications - Global, Direct Tel: +1-484-865-2020, Email: halstrd@wyeth.com . OgilvyHealthPR: Mary Barrington-Ward, Tel: +44-207-108-6066, Email: mary.barrington-ward@ohpr.com ; Aba Edwards-Idun, Tel: +1-212-625-4171, Email: aba.edwards-idun@ohpr.com .

Contenido patrocinado